The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Rescue of ΔF508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small molecules
Abstract
Cystic fibrosis (CF) is a fatal genetic disease caused by mutations in cftr, a gene encoding a PKA-regulated Cl−channel. The most common mutation results in a deletion of phenylalanine at position 508 (ΔF508-CFTR) that impairs protein folding, trafficking, and channel gating in epithelial cells. In the airway, these defects alter salt and fluid transport, leading to chronic infection, inflammation, and loss of lung function. There are no drugs that specifically target mutant CFTR, and optimal treatment of CF may require repair of both the folding and gating defects. Here, we describe two classes of novel, potent small molecules identified from screening compound libraries that restore the function of ΔF508-CFTR in both recombinant cells and cultures of human bronchial epithelia isolated from CF patients. The first class partially corrects the trafficking defect by facilitating exit from the endoplasmic reticulum and restores ΔF508-CFTR-mediated Cl−transport to more than 10% of that observed in non-CF human bronchial epithelial cultures, a level expected to result in a clinical benefit in CF patients. The second class of compounds potentiates cAMP-mediated gating of ΔF508-CFTR and achieves single-channel activity similar to wild-type CFTR. The CFTR-activating effects of the two mechanisms are additive and support the rationale of a drug discovery strategy based on rescue of the basic genetic defect responsible for CF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA
Riordan, J. R., Rommens, J. M., Kerem, B.-S., Alon, N., Rozmahel, R., Grzelczak, Z., Zielenski, J., Lok, S., Plavsic, N., Chou, J.-L., et al. (1989) · Science · doi:10.1126/science.2475911 · Cited by 7,418
Zhang, J.-H., Chung, T. D. Y., & Oldenburg, K. R. (1999) · SLAS Discovery · doi:10.1177/108705719900400206 · Cited by 6,847
Cheng, S. H., Gregory, R. J., Marshall, J., Paul, S., Souza, D. W., White, G. A., O'Riordan, C. R., & Smith, A. E. (1990) · Cell · doi:10.1016/0092-8674(90)90148-8 · Cited by 1,792
Degradation of CFTR by the ubiquitin-proteasome pathway
Ward, C. L., Omura, S., & Kopito, R. R. (1995) · Cell · doi:10.1016/0092-8674(95)90240-6 · Cited by 1,304
Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive
Denning, G. M., Anderson, M. P., Amara, J. F., Marshall, J., Smith, A. E., & Welsh, M. J. (1992) · Nature · doi:10.1038/358761a0 · Cited by 1,234
Matsui, H., Grubb, B. R., Tarran, R., Randell, S. H., Gatzy, J. T., Davis, C. W., & Boucher, R. C. (1998) · Cell · doi:10.1016/s0092-8674(00)81724-9 · Cited by 1,169
Structure and Function of the CFTR Chloride Channel
SHEPPARD, D. N., & WELSH, M. J. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.s23 · Cited by 1,018
Mutations in the Cystic Fibrosis Gene in Patients with Congenital Absence of the Vas Deferens
Chillón, M., Casals, T., Mercier, B., Bassas, L., Lissens, W., Silber, S., Romey, M.-C., Ruiz-Romero, J., Verlingue, C., Claustres, M., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506013322204 · Cited by 952
Low access resistance perforated patch recordings using amphotericin B
Rae, J., Cooper, K., Gates, P., & Watsky, M. (1991) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(91)90017-t · Cited by 917
Davis, P. B., Drumm, M., & Konstan, M. W. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.5.8912731 · Cited by 764
Altered chloride ion channel kinetics associated with the ΔF508 cystic fibrosis mutation
Dalemans, W., Barbry, P., Champigny, G., Jallat, S., Jallat, S., Dott, K., Dreyer, D., Crystal, R. G., Pavirani, A., Lecocq, J.-P., et al. (1991) · Nature · doi:10.1038/354526a0 · Cited by 707
New concepts of the pathogenesis of cystic fibrosis lung disease
Boucher, R. C. (2004) · European Respiratory Journal · doi:10.1183/09031936.03.00057003 · Cited by 640
Curcumin, a Major Constituent of Turmeric, Corrects Cystic Fibrosis Defects
Egan, M. E., Pearson, M., Weiner, S. A., Rajendran, V., Rubin, D., Glöckner-Pagel, J., Canny, S., Du, K., Lukacs, G. L., & Caplan, M. J. (2004) · Science · doi:10.1126/science.1093941 · Cited by 562
Pedemonte, N. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24898 · Cited by 538
Ma, T., Thiagarajah, J. R., Yang, H., Sonawane, N. D., Folli, C., Galietta, L. J. V., & Verkman, A. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0216112 · Cited by 536
Glycerol Reverses the Misfolding Phenotype of the Most Common Cystic Fibrosis Mutation
Sato, S., Ward, C. L., Krouse, M. E., Wine, J. J., & Kopito, R. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.2.635 · Cited by 519
Ward, C. L., & Kopito, R. R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47306-1 · Cited by 486
Mutations in CFTR associated with mild-disease-form CI- channels with altered pore properties
Sheppard, D. N., Rich, D. P., Ostedgaard, L. S., Gregory, R. J., Smith, A. E., & Welsh, M. J. (1993) · Nature · doi:10.1038/362160a0 · Cited by 467
Pathophysiology of Gene-Targeted Mouse Models for Cystic Fibrosis
GRUBB, B. R., & BOUCHER, R. C. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.s193 · Cited by 410
Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study
McKone, E. F., Emerson, S. S., Edwards, K. L., & Aitken, M. L. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13368-5 · Cited by 397
Lukacs, G. L., Mohamed, A., Kartner, N., Chang, X. B., Riordan, J. R., & Grinstein, S. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06954.x · Cited by 396
Rubenstein, R. C., Egan, M. E., & Zeitlin, P. L. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119788 · Cited by 389
Lukacs, G. L., Chang, X. B., Bear, C., Kartner, N., Mohamed, A., Riordan, J. R., & Grinstein, S. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80582-1 · Cited by 387
RUBENSTEIN, R. C., & ZEITLIN, P. L. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.2.9706088 · Cited by 340
Role of the Cytosolic Chaperones Hsp70 and Hsp90 in Maturation of the Cardiac Potassium Channel hERG
Ficker, E., Dennis, A. T., Wang, L., & Brown, A. M. (2003) · Circulation Research · doi:10.1161/01.res.0000079028.31393.15 · Cited by 323
Noone, P. G., Zhou, Z., Silverman, L. M., Jowell, P. S., Knowles, M. R., & Cohn, J. A. (2001) · Gastroenterology · doi:10.1053/gast.2001.29673 · Cited by 307
Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis
Corey, M., Edwards, L., Levison, H., & Knowles, M. (1997) · The Journal of Pediatrics · doi:10.1016/s0022-3476(97)70025-8 · Cited by 283
Integration of endoplasmic reticulum signaling in health and disease
Aridor, M., & Balch, W. E. (1999) · Nature Medicine · doi:10.1038/10466 · Cited by 279
Busby, M. G., Jeffcoat, A. R., Bloedon, L. T., Koch, M. A., Black, T., Dix, K. J., Heizer, W. D., Thomas, B. F., Hill, J. M., Crowell, J. A., et al. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/75.1.126 · Cited by 262
Ulloa‐Aguirre, A., Janovick, J. A., Brothers, S. P., & Conn, P. M. (2004) · Traffic · doi:10.1111/j.1600-0854.2004.00232.x · Cited by 253
Kreda, S. M., Mall, M., Mengos, A., Rochelle, L., Yankaskas, J., Riordan, J. R., & Boucher, R. C. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-11-1010 · Cited by 249
cAMP-independent activation of CFTR Cl channels by the tyrosine kinase inhibitor genistein
Illek, B., Fischer, H., Santos, G. F., Widdicombe, J. H., Machen, T. E., & Reenstra, W. W. (1995) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1995.268.4.c886 · Cited by 208
Nanomolar Affinity Small Molecule Correctors of Defective ΔF508-CFTR Chloride Channel Gating
Yang, H., Shelat, A. A., Guy, R. K., Gopinath, V. S., Ma, T., Du, K., Lukacs, G. L., Taddei, A., Folli, C., Pedemonte, N., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303098200 · Cited by 202
Ficker, E., Zhao, S., Obejero-Paz, C. A., & Brown, A. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107345200 · Cited by 180
Cell-based assays and instrumentation for screening ion-channel targets
González, J. (1999) · Drug Discovery Today · doi:10.1016/s1359-6446(99)01383-5 · Cited by 178
Self-citationMa, T., Vetrivel, L., Yang, H., Pedemonte, N., Zegarra-Moran, O., Galietta, L. J. V., & Verkman, A. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205932200 · Cited by 175
Devor, D. C., Bridges, R. J., & Pilewski, J. M. (2000) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2000.279.2.c461 · Cited by 170
Rapid endocytosis of the cystic fibrosis transmembrane conductance regulator chloride channel.
Prince, L. S., Workman, R., & Marchase, R. B. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.5192 · Cited by 160
HERG-Lite®: A novel comprehensive high-throughput screen for drug-induced hERG risk
Wible, B. A., Hawryluk, P., Ficker, E. K., et al. (2005) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2005.03.008 · Cited by 150
Pedemonte, N., Sonawane, N. D., Taddei, A., Hu, J., Zegarra‐Moran, O., Suen, Y. F., Robins, L. I., Dicus, C. W., Willenbring, D., Nantz, M. H., et al. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.010959 · Cited by 146
Glibenclamide blockade of CFTR chloride channels
Schultz, B. D., DeRoos, A. D., Venglarik, C. J., Singh, A. K., Frizzell, R. A., & Bridges, R. J. (1996) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1996.271.2.l192 · Cited by 135
Self-citationLung Disease Associated with the IVS8 5T Allele of the CFTR Gene
Noone, P. G., Pue, C. A., Zhou, Z., Friedman, K. J., Wakeling, E. L., Ganeshananthan, M., Simon, R. H., Silverman, L. M., & Knowles, M. R. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.5.2003160 · Cited by 119
Song, Y., Sonawane, N. D., Salinas, D. B., Qian, L., Pedemonte, N., Galietta, L. J. V., & Verkman, A. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407308200 · Cited by 115
Missing Cl conductance in cystic fibrosis
Quinton, P. (1986) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1986.251.4.c649 · Cited by 113
Cystic Fibrosis F508del Patients Have Apically Localized CFTR in a Reduced Number of Airway Cells
Penque, D., Mendes, F., Beck, S., Farinha, C. M., Pacheco, P. R., Nogueira, P., Lavinha, J., Malhó, R., & Amaral, M. D. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780090 · Cited by 101
A ubiquitin-based tagging system for controlled modulation of protein stability
Stack, J. H., Whitney, M. A., Rodems, S. M., & Pollok, B. A. (2000) · Nature Biotechnology · doi:10.1038/82422 · Cited by 89
Self-citationDefective fluid transport by cystic fibrosis airway epithelia.
Smith, J. J., Karp, P. H., & Welsh, M. J. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117087 · Cited by 85
Rescue of ΔF508 and Other Misprocessed CFTR Mutants by a Novel Quinazoline Compound
Loo, T. W., Bartlett, M. C., & Clarke, D. M. (2005) · Molecular Pharmaceutics · doi:10.1021/mp0500521 · Cited by 78
Silvis, M. R., Picciano, J. A., Bertrand, C. A., Weixel, K. M., Bridges, R. J., & Bradbury, N. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212843200 · Cited by 58
Marivingt‐Mounir, C., Norez, C., Dérand, R., Bulteau‐Pignoux, L., Dung, N. H., Viossat, B., Morgant, G., Becq, F., VIERFOND, J. ‐., & Mettey, Y. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0308848 · Cited by 56
Ho, L., Samways, J., Porteous, D. J., Dorin, Carothers, A. D., Greening, A., & Innes, J. (1997) · European Respiratory Journal · doi:10.1183/09031936.97.10092018 · Cited by 56
Relation of sweat chloride concentration to severity of lung disease in cystic fibrosis
Davis, P. B., SCHLUCHTER, M. D., & Konstan, M. W. (2004) · Pediatric Pulmonology · doi:10.1002/ppul.20054 · Cited by 53
Mall, M. A., Wissner, A., Seydewitz, H. H., et al. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703520 · Cited by 42
An improved method to obtain highly differentiated monolayers of human bronchial epithelial cells
Galietta, L. J. V., Lantero, S., Gazzolo, A., Sacco, O., Romano, L., Rossi, G., & Zegarra‐Moran, O. (1998) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-998-0081-2 · Cited by 41
Fajac, I., Hubert, D., Bienvenu, T., Richaud-Thiriez, B., Matran, R., Jc, K., DALL'AVA-SANTUCCI, J., & Dusser, D. J. (1998) · European Respiratory Journal · doi:10.1183/09031936.98.12061295 · Cited by 28
An Atypical Sorting Determinant in the Cytoplasmic Domain of P-Selectin Mediates Endosomal Sorting
Straley, K. S., Daugherty, B. L., Aeder, S. E., Hockenson, A. L., Kim, K., & Green, S. A. (1998) · Molecular Biology of the Cell · doi:10.1091/mbc.9.7.1683 · Cited by 24
Self-citation
Cited by
Update on Key Emerging Challenges in Cystic Fibrosis
Jennings, M. T., Riekert, K. A., & Boyle, M. P. (2014) · Medical Principles and Practice · doi:10.1159/000357646 · Cited by 3,648
Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR
Wainwright, C. E., Elborn, J. S., Ramsey, B. W., Marigowda, G., Huang, X., Cipolli, M., Colombo, C., Davies, J. C., De Boeck, K., Flume, P. A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1409547 · Cited by 1,622
Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770
Van Goor, F., Hadida, S., Grootenhuis, P. D. J., Burton, B., Cao, D., Neuberger, T., Turnbull, A., Singh, A., Joubran, J., Hazlewood, A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904709106 · Cited by 1,228
Self-citationCorrection of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809
Van Goor, F., Hadida, S., Grootenhuis, P. D. J., Burton, B., Stack, J. H., Straley, K. S., Decker, C. J., Miller, M., McCartney, J., Olson, E. R., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105787108 · Cited by 1,088
Self-citationThe future of cystic fibrosis care: a global perspective
Bell, S. C., Mall, M. A., Gutierrez, H., Macek, M., Madge, S., Davies, J. C., Burgel, P.-R., Tullis, E., Castaños, C., Castellani, C., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30337-6 · Cited by 974
Metadata
- Authors
- Van Goor, F., Straley, K. S., Cao, D., González, J., Hadida, S., Hazlewood, A., Joubran, J., Knapp, T., Makings, L. R., Miller, M., Neuberger, T., Olson, E., Panchenko, V., Rader, J., Singh, A., Stack, J. H., Tung, R., Grootenhuis, P. D. J., & Negulescu, P.
- Venue
- American Journal of Physiology-Lung Cellular and Molecular Physiology
- Publisher
- American Physiological Society
- Published
- 2006-06
- Volume
- 290
- Issue
- 6
- Pages
- L1117-L1130
- ISSN
- 1040-0605 (ISSN-L)
- 1522-1504
- OpenAlex
- W2125460059
- Cited by
- 512
- References
- 56
- FWCI
- 21.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.